|Up a level|
Altmannsberger, Philipp and Holler, Ernst and Andreesen, Reinhard and Krause, Stefan W. (2007) Amphotericin B deoxycholate: no significant advantage of a 24 h over a 6 h infusion schedule. The Journal of antimicrobial chemotherapy 60 (1), pp. 180-2.
Fischer, Karin and Hoffmann, Petra and Voelkl, Simon and Meidenbauer, Norbert and Ammer, Julia and Edinger, Matthias and Gottfried, Eva and Schwarz, Sabine and Rothe, Gregor and Hoves, Sabine and Renner, Kathrin and Timischl, Birgit and Mackensen, Andreas and Kunz-Schughart, Leoni and Andreesen, Reinhard and Krause, Stefan W. and Kreutz, Marina (2007) Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109 (9), pp. 3812-9.
Rehli, Michael and Sulzbacher, Sabine and Pape, Sabine and Ravasi, Timothy and Wells, Christine A. and Heinz, Sven and Söllner, Liane and El Chartouni, Carol and Krause, Stefan W. and Steingrimsson, Eirikur and Hume, David A. and Andreesen, Reinhard (2005) Transcription factor Tfec contributes to the IL-4-inducible expression of a small group of genes in mouse macrophages including the granulocyte colony-stimulating factor receptor. Journal of immunology (Baltimore, Md. : 1950) 174 (11), pp. 7111-22.
Haenssle, Holger A. and Krause, Stefan W. and Emmert, Steffen and Zutt, Markus and Kretschmer, Lutz and Schmidberger, Heinz and Andreesen, Reinhard and Soruri, Afsaneh (2004) Hybrid cell vaccination in metastatic melanoma: clinical and immunologic results of a phase I/II study. Journal of immunotherapy (Hagerstown, Md. : 1997) 27 (2), pp. 147-55.
Reichle, Albrecht and Bross, Klaus and Vogt, Thomas and Bataille, Frauke and Wild, Peter and Berand, Anna and Krause, Stefan W. and Andreesen, Reinhard (2004) Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma. Cancer 101 (10), pp. 2247-56.
Krause, Stefan W. and Gnad, Marcus and Reichle, Albrecht and Andreesen, Reinhard (2002) Adoptive therapy with monocyte-derived macrophages in the setting of high-dose chemotherapy and peripheral blood stem cell transplantation. British journal of haematology 116 (4), pp. 920-2.